• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以2-氯-2'-脱氧腺苷5'-三磷酸为底物时人DNA聚合酶α和β的活性以及掺入对链延伸的定量影响。

Activity of human DNA polymerases alpha and beta with 2-chloro-2'-deoxyadenosine 5'-triphosphate as a substrate and quantitative effects of incorporation on chain extension.

作者信息

Chunduru S K, Appleman J R, Blakley R L

机构信息

Department of Biochemical and Clinical Pharmacology, St. Jude Children's Research Hospital, Memphis, Tennessee 38101.

出版信息

Arch Biochem Biophys. 1993 Apr;302(1):19-30. doi: 10.1006/abbi.1993.1175.

DOI:10.1006/abbi.1993.1175
PMID:8470896
Abstract

When 2-chloro-2'-deoxyadenosine 5'-triphosphate (CldATP) is incorporated into DNA by human polymerases alpha and beta (Hpol alpha, Hpol beta) the rate of chain extension decreases. In the present study primer extension has been quantitated by estimating the concentration of each successive oligonucleotide product at a series of time points. This has permitted calculation of pseudo-first-order rate constants for successive nucleotide additions to primer. By this method it has been shown that rate constants for CldATP addition are 79-100% of those for dATP in the case of Hpol alpha, and 26-153% with Hpol beta. The concentrations of CldATP for half maximum velocity is 0.6 microM for Hpol alpha, and 6 microM for Hpol beta, each about twice the value for dATP. Thus, CldATP is a good substrate for both enzymes but is more efficiently used by Hpol alpha. Addition of a single analogue residue by Hpol beta to any of seven primers decreases the rate constant for addition of the next nucleotide to 2-7% of that after dAMP addition and further extension is negligible. Consecutive additions of analogue residues by Hpol alpha progressively decrease the rate of subsequent extension, and after five consecutive additions extension virtually terminates. These effects probably make a major contribution to the cytotoxicity of chlorodeoxyadenosine and its therapeutic usefulness as an antileukemic agent.

摘要

当2-氯-2'-脱氧腺苷5'-三磷酸(CldATP)被人α和β聚合酶(Hpolα、Hpolβ)掺入DNA时,链延伸速率降低。在本研究中,通过估计一系列时间点上每个连续寡核苷酸产物的浓度来定量引物延伸。这使得能够计算向引物连续添加核苷酸的伪一级速率常数。通过这种方法已表明,在Hpolα的情况下,添加CldATP的速率常数是添加dATP的速率常数的79 - 100%,而在Hpolβ的情况下为26 - 153%。Hpolα达到最大速度一半时的CldATP浓度为0.6微摩尔,Hpolβ为6微摩尔,各自约为dATP值的两倍。因此,CldATP是这两种酶的良好底物,但Hpolα对其利用效率更高。Hpolβ向七种引物中的任何一种添加单个类似物残基会使添加下一个核苷酸的速率常数降至添加dAMP后速率常数的2 - 7%,并且进一步延伸可忽略不计。Hpolα连续添加类似物残基会逐渐降低后续延伸的速率,连续添加五次后延伸实际上终止。这些效应可能对氯脱氧腺苷的细胞毒性及其作为抗白血病药物的治疗效用起主要作用。

相似文献

1
Activity of human DNA polymerases alpha and beta with 2-chloro-2'-deoxyadenosine 5'-triphosphate as a substrate and quantitative effects of incorporation on chain extension.以2-氯-2'-脱氧腺苷5'-三磷酸为底物时人DNA聚合酶α和β的活性以及掺入对链延伸的定量影响。
Arch Biochem Biophys. 1993 Apr;302(1):19-30. doi: 10.1006/abbi.1993.1175.
2
Incorporation of 2-halogeno-2'-deoxyadenosine 5-triphosphates into DNA during replication by human polymerases alpha and beta.在复制过程中,人α和β聚合酶将2-卤代-2'-脱氧腺苷5-三磷酸掺入DNA。
J Biol Chem. 1990 Mar 5;265(7):4033-40.
3
Effects of 2-chloro-2'-deoxyadenosine 5'-triphosphate on DNA synthesis in vitro by purified bacterial and viral DNA polymerases.2-氯-2'-脱氧腺苷5'-三磷酸对纯化的细菌和病毒DNA聚合酶体外DNA合成的影响。
Biochemistry. 1991 Jan 15;30(2):547-54. doi: 10.1021/bi00216a032.
4
Steady-state and pre-steady-state kinetic analysis of dNTP insertion opposite 8-oxo-7,8-dihydroguanine by Escherichia coli polymerases I exo- and II exo-.大肠杆菌聚合酶 I 外切酶和 II 外切酶对与 8-氧代-7,8-二氢鸟嘌呤相对的脱氧核苷三磷酸插入的稳态和预稳态动力学分析。
Biochemistry. 1996 Jul 30;35(30):9840-9. doi: 10.1021/bi960485x.
5
[New nucleotide inhibitors of human DNA polymerase alpha].[人类DNA聚合酶α的新型核苷酸抑制剂]
Mol Biol (Mosk). 1995 May-Jun;29(3):689-700.
6
Incorporation of fludarabine and 1-beta-D-arabinofuranosylcytosine 5'-triphosphates by DNA polymerase alpha: affinity, interaction, and consequences.DNA聚合酶α对氟达拉滨和1-β-D-阿拉伯呋喃糖基胞嘧啶5'-三磷酸的掺入:亲和力、相互作用及后果。
Clin Cancer Res. 1997 Aug;3(8):1347-55.
7
Differential inhibition of DNA polymerases of calf thymus by 9-beta-D-arabinofuranosyladenine-5'-triphosphate.9-β-D-阿拉伯呋喃糖基腺嘌呤-5'-三磷酸对小牛胸腺DNA聚合酶的差异性抑制作用。
J Biochem. 1978 Sep;84(3):727-32. doi: 10.1093/oxfordjournals.jbchem.a132178.
8
Two novel dATP analogs for DNA photoaffinity labeling.用于DNA光亲和标记的两种新型脱氧三磷酸腺苷类似物。
Nucleic Acids Res. 2000 Nov 1;28(21):4382-90. doi: 10.1093/nar/28.21.4382.
9
Significant contribution of the 3'→5' exonuclease activity to the high fidelity of nucleotide incorporation catalyzed by human DNA polymerase ϵ.3'→5'核酸外切酶活性对人DNA聚合酶ϵ催化的核苷酸掺入高保真度的重要贡献。
Nucleic Acids Res. 2014 Dec 16;42(22):13853-60. doi: 10.1093/nar/gku1184. Epub 2014 Nov 20.
10
Insertion and extension of acyclic, dideoxy, and ara nucleotides by herpesviridae, human alpha and human beta polymerases. A unique inhibition mechanism for 9-(1,3-dihydroxy-2-propoxymethyl)guanine triphosphate.疱疹病毒科、人α和人β聚合酶对无环、双脱氧和阿拉伯核苷酸的插入与延伸。9-(1,3-二羟基-2-丙氧甲基)鸟嘌呤三磷酸独特的抑制机制。
J Biol Chem. 1988 Mar 15;263(8):3898-904.

引用本文的文献

1
Quantitation of synergism of arabinosylcytosine and cladribine against the growth of arabinosylcytosine-resistant human lymphoid cells.阿糖胞苷与克拉屈滨对阿糖胞苷耐药人淋巴细胞生长协同作用的定量分析。
J Cancer Res Clin Oncol. 2005 Sep;131(9):609-16. doi: 10.1007/s00432-005-0012-5. Epub 2005 Oct 20.
2
2-Chloro-2'-deoxyadenosine: alteration of DNA:TATA element binding protein (TBP) interactions.2-氯-2'-脱氧腺苷:DNA与TATA元件结合蛋白(TBP)相互作用的改变
J Mol Model. 2004 Feb;10(1):32-7. doi: 10.1007/s00894-003-0163-8. Epub 2003 Nov 11.
3
2-Chloro-2'-deoxyadenosine monophosphate residues in DNA enhance susceptibility to 3'-->5' exonucleases.
DNA中的2-氯-2'-脱氧腺苷单磷酸残基会增强对3'→5'核酸外切酶的敏感性。
Biochem J. 1994 Sep 1;302 ( Pt 2)(Pt 2):567-71. doi: 10.1042/bj3020567.
4
Cladribine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in haematological malignancies.克拉屈滨。对其血液系统恶性肿瘤的药效学、药代动力学特性及治疗潜力的综述。
Drugs. 1993 Nov;46(5):872-94. doi: 10.2165/00003495-199346050-00007.